tiprankstipranks

PCRA Trust - New Portfolio

Dela Amoussou

PCRA Trust
Individual Investor
Ranked #135,161 out of 793,417 TipRanks' Investors
Success Rate
58%
163 out of 280
profitable transactions
Average Return
17.06%
Average return
per transaction
Share this portfolio:

Portfolio Gain

1-Month Return▼ 3.56%
6-Month Return▲ 2.41%
12-Month Return▲ 16.66%
YTD Return▲ 1.75%
Total Return▲ 34.93%

Best Trade

Opened at
Closed at-
Gain▲ 547.08%

Bio

Performance

26.01%0-26.01%
▼ 13.14%
▲ 2.34%
▲ 2.73%
Aug 2024
▲ 2.93%
▲ 2.10%
▲ 1.70%
Sep 2024
▲ 10.00%
▼ 0.89%
▼ 1.40%
Oct 2024
▲ 26.01%
▲ 5.96%
▲ 7.13%
Nov 2024
▲ 5.34%
▼ 2.41%
▼ 5.38%
Dec 2024
▲ 5.88%
▲ 2.69%
▲ 4.44%
Jan 2025
▼ 12.86%
▼ 1.27%
▲ 0.64%
Feb 2025
▲ 7.47%
▼ 3.09%
▼ 3.20%
Mar 2025
TipRanks AverageS&P 500Investor Portfolio
▼ 13.14%▲ 2.34%▲ 2.73%
▲ 2.93%▲ 2.10%▲ 1.70%
▲ 10.00%▼ 0.89%▼ 1.40%
▲ 26.01%▲ 5.96%▲ 7.13%
▲ 5.34%▼ 2.41%▼ 5.38%
▲ 5.88%▲ 2.69%▲ 4.44%
▼ 12.86%▼ 1.27%▲ 0.64%
▲ 7.47%▼ 3.09%▼ 3.20%

Recent Activity

Company Name
% of Portfolio
Return
No. of Transactions
Last Transaction
Date
AstraZeneca
2.33%
▲ 13.01%
5
Buy
Mar 25, 2025
Fidelity Enhanced Large Cap Growth ETF
1.56%
▼ 1.68%
8
Buy
Mar 25, 2025
Fidelity Enhanced Large Cap Core ETF
1%
▼ 1.77%
4
Buy
Mar 25, 2025
Miller Industries
1.36%
▼ 21.09%
2
Buy
Mar 24, 2025
Realty Income
1.88%
▲ 1.24%
20
Buy
Mar 14, 2025
J.P. Morgan Nasdaq Equity Premium Income ETF
1.26%
▼ 2.05%
3
Buy
Mar 12, 2025
JPMorgan Equity Premium Income ETF
2.9%
▲ 6.20%
21
Buy
Mar 05, 2025
Target
1.67%
▼ 22.79%
4
Buy
Mar 03, 2025
Simplify Volatility Premium ETF
2.15%
▼ 10.29%
24
Buy
Feb 28, 2025
Costco
1.45%
▲ 48.01%
7
Buy
Feb 21, 2025
Apple
6.98%
▲ 38.38%
8
Buy
Feb 14, 2025
Dorchester Minerals
0.55%
▲ 72.33%
7
Buy
Feb 14, 2025
Novartis
1.71%
▲ 11.38%
1
Buy
Jan 23, 2025
GlaxoSmithKline
1.19%
▲ 13.82%
1
Buy
Jan 23, 2025
Lucid Group
0.81%
▼ 75.74%
4
Buy
Jan 17, 2025
Hims & Hers Health
1.15%
▲ 70.02%
4
Sell
Jan 17, 2025
Shopify
1.7%
▲ 39.62%
12
Sell
Jan 17, 2025
VICI Properties
1.6%
▲ 1.72%
8
Buy
Jan 10, 2025
Vistra Energy
0.03%
▲ 186.92%
8
Buy
Dec 31, 2024
Gilead Sciences
1.7%
▲ 5.19%
3
Buy
Dec 31, 2024